Methylation Score Can ID Risk for Cervical Adenocarcinomas
Methylation score had sensitivity of 74 percent, specificity of 89 percent for adenocarcinoma in situ/adenocarcinoma
CDC Panel Gives Support to New COVID-19 Booster Shots
New booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating
ChatGPT Accurately Handles Questions About Vaccine Hesitancy
Findings seen for 50 most common questions about false information, myths, and false and true contraindications
Flu Vaccine Cut Risk for Influenza-Linked Hospitalizations in 2023
Interim data show vaccine effectiveness of 51.9 percent in five South American countries during their flu season
FDA Approves New COVID-19 Booster Shots
New booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating
Severity Reduced With Mpox Reinfection, Postvaccination Infection
Shorter disease course with less mucosal disease seen on reinfection versus initial infection
Providers Have Inadequate Awareness of PCV20 Vaccination Recommendations
Two-thirds of health care providers agree with expanding recommendations for new PCV20
Early Clean Intermittent Catheterization Recommended With Neurogenic Bladder
High-grade vesicoureteral reflux is crucial risk factor for recurrent febrile urinary tract infections in children
Hepatitis C Virus Still Leading Cause of Hepatocellular Cancer in Men
Since 2017, leading cause of HCC is NAFLD among women; increases in ALD- and NAFLD-HCC seen since 2015
FDA Approval of New COVID-19 Boosters Could Come by Friday
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating
